Clinical Trials Browser

OTHER × Ovarian Neoplasms × Bendamustine Hydrochloride × Clear all

NCT06483048 2026-03-16

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

Phase 1 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00867503 2018-07-24

Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer

Phase 2 Completed

10 enrolled 12 charts

Ovarian Neoplasms